Cancer Treatment Reviews
Volume 31, Issue 6 , Pages 439-447 , October 2005

The pregnant mother with breast cancer: Diagnostic and therapeutic management

References 

  1. Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003;189:1128–1135
  2. Antonelli NM, Dotters DJ, Katz VL, Kuller JA. Cancer in pregnancy – a review of the literature: parts 1 and 2. Obstet Gynecol Surv. 1996;51:125–142
  3. Pavlidis NA. Coexistence of pregnancy and malignancy. The Oncologist. 2002;7:279–287
  4. Farine D, Kelly EN. The pregnant patient with malignant disease: maternal–fetal conflict. In:  Koren G,  Lishner M,  Farine D editor. Cancer in pregnancy. Cambridge: Cambridge University Press; 1996;p. 15–26
  5. Oduncu FS, Kimming R, Hepp H, Emmerich B. Cancer in pregnancy: maternal–fetal conflict. J Cancer Res Clin Oncol. 2003;129:133–146
  6. White TT. Carcinoma of the breast in the pregnant and nursing patient. Am J Obstet Gynecol. 1955;69:1277–1286
  7. In:  Ries LAG,  Eisner NP,  Kosary CL, et al. editor. SEER cancer statistics review 1973–1999. Bethesda, ND: National Cancer Institute; 2002;Available from http://seer.cancer.gov/csr
  8. Wallack MK, Wolf JA, et al. Gestational carcinoma of the female breast. Curr Probl Cancer. 1983;7:1–58
  9. Nugent P, O’ Connell TX. Breast cancer and pregnancy. Arch Surg. 1985;120:1221–1224
  10. Saunders CM, Baum M. Breast cancer and pregnancy: a review. J R Soc Med. 1993;86:162–165
  11. Ishida T, Yokoe T, Kasumi F, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res. 1992;83:1143–1149
  12. Applewhite RR, Smith LR, De Vincenti F. Carcinoma of the breast associated with pregnancy and lactation. Am Surg. 1973;39:101–104
  13. Sorosky JI, Scott-Conner CEH. Breast disease complicating pregnancy. Obst Gynecol Clin North Amer. 1998;25(2):353–363
  14. Byrd BF, Bayer DS, Robertson JC, et al. Treatment of breast tumors associated with pregnancy and lactation. Ann Surg. 1962;155:940–947
  15. Slavin JL, Billson VR, Ostor AG. Nodular breast lesions during pregnancy and lactation. Histopathology. 1993;22:481–485
  16. Collins JC, Liao S, Wile AG. Surgical management of breast masses in pregnant women. J Reprod Med. 1995;40:785–788
  17. Jiminez JF, Ryals RO, Cohen C. Spontaneous breast infarction associated with pregnancy presenting as a palpable mass. J Surg Oncol. 1986;32:174–178
  18. Middleton LP, Amin M, Gwyn G, et al. Breast carcinoma in pregnant women. Assessment of clinicopathologic and immunohistochemical features. Cancer. 2003;98:1055–1060
  19. Parente JT, Amsel M, Lerner R, Chinea F. Breast cancer associated with pregnancy. Obstet Gynecol. 1988;71:861–864
  20. Tobon H, Hozowitz LF. Breast cancer during pregnancy. Breast Dis. 1993;6:127–134
  21. King RM, Welch JS, Martin JK, Coulam CB. Carcinoma of the breast associated with pregnancy. Surg Gynecol Obstet. 1985;160:228–232
  22. Holleb A, Farrow JH. The relation of carcinoma of the breast and pregnancy in 283 patients. Surg Gynecol Obstet. 1962;115:65–71
  23. Lethaby AE, O’ Neill MA, Mason BH, et al. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Int J Cancer. 1996;67:751–755
  24. Isaacs J. Cancer of the breast in pregnancy. Surg Clin North Am. 1995;75:47–51
  25. Ribeiro G, Jones DA, Jones M. Carcinoma of the breast associated with pregnancy. Br J Surg. 1986;73:607–609
  26. Elledge RM, Ciocca DR, Langone G, McGuire WL. Estrogen receptor, progesterone receptor and Her-2/neu protein in breast cancer from pregnant patients. Cancer. 1993;71:2499–2506
  27. Bonnier P, Romain S, Dilhuydy J, et al. Influence of pregnancy on the outcome of breast cancer: a case – control study. Int J Cancer. 1997;72:720–727
  28. Shousha S. Breast carcinoma presenting during or shortly after pregnancy and lactation. Arch Pathol Lab Med. 2000;124:1053–1060
  29. Shen T, Vortmeyer AO, Zhuang Z, Tavassoli FA. High frequency of allelic loss of BRCA 2 gene in pregnancy-associated breast carcinoma. J Natl Cancer Inst. 1999;91:1686–1687
  30. Johannsson O, Loman N, Borg A, Olsson H. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers. Lancet. 1998;352:1359–1360
  31. Novotny D, Maygarden S, Shermer R, Frable W. Fine needle aspiration of bening and malignant breast masses associated with pregnancy. Acta Cytol. 1991;35:676–686
  32. Mitre B, Kaubour A, Mauser N. Fine needle aspiration biopsy of breast carcinoma in pregnancy and lactation. Acta Cytol. 1997;41:1121–1130
  33. Shannon J, Douglas-Jones AG, Dallimore NS. Conversion to core-biopsy in preoperative diagnosis of breast lesions: is it justified by results?. J Clin Pathol. 2001;54:762–765
  34. Moore HCF, Foster RS. Breast cancer and pregnancy. Semin Oncol. 2000;27:646–653
  35. Petrek JA. Breast cancer during pregnancy. Cancer. 1994;74:518–527
  36. Advisory Committee on the Biological Effects of Ionizining Radiation. National Research Council. National Academy of Sciences. The effects on populations of exposure to low levels of ionizing radiation. Washington, DC: National Academy Press; 1980.
  37. Palhemus D, Koch R. Leukemia and medical irradiation. Pediatrics. 1959;23:453–461
  38. Bentuz Y. Prenatal irradiation and cancer. In:  Koren G,  Lishner M,  Farine D editor. Cancer in pregnancy. Maternal and fetal risks. Cambridge: Cambridge University Press; 1996;p. 159–167
  39. Mole RH. Childhood cancer after prenatal exposure to diagnostic X-ray examinations in Britain. Br J Cancer. 1990;62:152–168
  40. Nicklas A, Baker M. Imaging strategies in pregnant cancer patients. Semin Oncol. 2000;27:623–632
  41. Kuerer H, Gwyn K, Ames F, et al. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery. 2002;131:108–110
  42. Gentilini O, Cremonesi M, Trifiro G, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol. 2004;15:1348–1351
  43. Zemlickis D, Lishner M, Degendorfer P, et al. Maternal and fetal outcome following breast cancer in pregnancy. In:  Koren G,  Lishner M,  Farine D editor. Cancer in pregnancy. Maternal and fetal risks. Cambridge: Cambridge University Press; 1996;p. 95–106
  44. Berry DL, Theriault RL, Holmes FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999;17:855–861
  45. Petrek JA, Dukoff R, Rogatko A. Prognosis of pregnancy-associated breast cancer. Cancer. 1991;67:869–872
  46. Doll D, Ringeberg Q, Yarbro J. Antineoplastic agents and pregnancy. Semin Oncol. 1989;16:337–346
  47. Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy: a literature review. Arch Surg. 2003;138:91–98
  48. Turchi J, Villasis C. Anthracyclines in the treatmnent of malignancy in pregnancy. Cancer. 1988;61:435–440
  49. Peccatori F, Martinelli G. Chemotherapy during pregnancy: what is really safe?. Lancet Oncol. 2004;5:398
  50. Willemse PHB, van der Sijde R, Sleijfer DTh. Combination chemotherapy and radiation for stage IV breast cancer during pregnancy. Gyn Oncology. 1990;36:281–284
  51. Giacalone PL, Laffargue F, Benos P. Chemotherapy for breast carcinoma during pregnancy. Cancer. 1999;86:2266–2272
  52. De Santis M, Lucchese A, De Carolis S, et al. Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur J Cancer Care. 2000;9:235–237
  53. Gonzalez-Angulo AM, Walters RS, Carpenter RJ, et al. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer. 2004;5:317–319
  54. Antypas C, Sandilos P, Kouvaris J, et al. Fetal dose evaluation durign breast cancer radiotherapy. Int J Radiat Oncol Biol Phys. 1998;40:995–999
  55. Fenig E, Mishaeli M, Kalish Y, Lishner M. Pregnancy and radiation. Cancer Treat Rev. 2001;27:1–7
  56. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5:283–291
  57. Buekers TE, Thomas L. Chemotherapy in pregnancy. Obstet Gynecol. 1998;25:323–327
  58. Zemlickis D, Lishner M, Koren G. Review of fetal effects of cancer chemotherapeutic agents. In:  Koren G,  Lishner M,  Farine D editor. Cancer in pregnancy. Maternal and fetal risks. Cambridge: Cambridge University Press; 1996;p. 168–180
  59. Zemlickis D, Lishner M, Degendorfer P, et al. Fetal outcome following in utero exposure to cancer chemotherapy: the Toronto study. In:  Koren G,  Lishner M,  Farine D editor. Cancer in pregnancy. Maternal and fetal risks. Cambridge: Cambridge University Press; 1996;p. 181–188
  60. Egan PC, Costanza ME, Dodion P, et al. Doxorubicin and cisplatin excretion into human milk. Cancer Treat Rep. 1985;69:1387–1389
  61. Amato D, Niblett JS. Neutropenia from cyclophosphamide in breast milk. Med J Aust. 1977;1:383–384
  62. Durodola JI. Administration of cyclophosphamide during late pregnancy and early lactation: a case report. J Natl Med Assoc. 1979;71:165–166
  63. Johns DG, Rutherford LD, Keighton PC, Vogel CL. Secretion of methotrexate into human milk. Am J Obstet Gynecol. 1972;112:978–980
  64. Wiebe VJ, Sipila PEH. Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol. 1994;16:75–112
  65. Zemlickis D, Klein J, Moselhy G, Koren G. Cisplatin protein binding in pregnancy and the neonatal period. Med Pediatr Oncol. 1994;23:476–479
  66. Mulvihill JJ, Stewart KR. A registry of pregnancies exposed to chemotherapeutic agents. Teratology. 1986;33:80
  67. Randall T. National registry seeks scarce data on pregnancy outcomes during chemotherapy. JAMA. 1993;269:323
  68. Briggs GC, Freeman RK, Yaffee SJ. A reference guide to fetal and neonatal risk: drugs in pregnancy and lactation. 5th ed.. Philadelphia: Williams & Wilkins; 1998;
  69. Medlock ES, Kaplan DL, Cecchini M, et al. Granulocyte colony-stimulating factor crosses the placenta and stimulates fetal rat granulopoiesis. Blood. 1993;81:916–922
  70. Widness JA, Sawyer ST, Schmidt RL, Chestnut DH. Lack of maternal to fetal transfer of 125 I-labelled erythropoietin in sheep. J Dev Physiol. 1991;15:139–143
  71. Scott LL, Ramin SM, Richey M, et al. Erythropoietin use in pregnancy: two cases and a review of the literature. Am J Parinatol. 1995;12:22–24
  72. Illidge TM, Hussey M, Godden CW. Malignant hypercalemia in pregnancy and antenatal administration of intravenous pamidronate. Clin Oncol. 1996;8:257–258
  73. MacDougall M, LeGrand S, Walsh D. Symptom control in pregnant cancer patient. Semin Oncol. 2000;27:704–711
  74. Berkovitch M, Mazzota P, Greenberg R, Elbirt D, Addis A, et al. Metoclopramide for nausea and vomiting of pregnancy. A prospective multicentre international study. Am J Perinatol. 2002;19:311–316
  75. Einasson A, Maltepe C, Navioz Y, Kennedy D, Tau MP, Koren G. The safety of ondansentron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG. 2004;111:940–943
  76. Dildy GA, Moise KJ, Carpenter RJ, et al. Maternal malignancy metastatic to the products of conception: a review. Obstet Gynecol Surv. 1989;44:535–540
  77. Potter JF, Schoeneman M. Metastatis of maternal cancer to the placenta and fetus. Cancer. 1970;25:380–388
  78. Brahim BE, Mrad K, Driss M, et al. Placental metastasis of breast cancer. Gynecol Obstet Fertil. 2001;29(7–8):545–548
  79. Lehner R, Strohmer H, Jirecek S, et al. Placental insufficiency and maternal death caused by advanced stage of breast cancer in third trimester. Eur J Obst Gynec Reprod Biol. 2001;99:272–273

PII: S0305-7372(05)00084-8

doi: 10.1016/j.ctrv.2005.04.010

Cancer Treatment Reviews
Volume 31, Issue 6 , Pages 439-447 , October 2005

Article Tools